Computer-guided design of optimal microbial consortia for immune system modulation

Author:

Stein Richard R1234ORCID,Tanoue Takeshi56,Szabady Rose L7,Bhattarai Shakti K8,Olle Bernat7,Norman Jason M7,Suda Wataru69,Oshima Kenshiro9,Hattori Masahira9,Gerber Georg K10ORCID,Sander Chris1411,Honda Kenya56,Bucci Vanni81213ORCID

Affiliation:

1. cBio Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, United States

2. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, United States

3. Department of Systems Biology, Harvard Medical School, Boston, United States

4. Broad Institute of MIT and Harvard, Cambridge, United States

5. RIKEN Center for Integrative Medical Sciences, Yokohama, Japan

6. Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan

7. Vedanta Biosciences, Cambridge, United States

8. Engineering and Applied Sciences PhD Program, University of Massachusetts Dartmouth, North Dartmouth, United States

9. Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan

10. Massachusetts Host-Microbiome Center, Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States

11. Department of Cell Biology, Harvard Medical School, Boston, United States

12. Department of Biology, University of Massachusetts Dartmouth, North Dartmouth, United States

13. Center for Microbial Informatics and Statistics, University of Massachusetts Dartmouth, North Dartmouth, United States

Abstract

Manipulation of the gut microbiota holds great promise for the treatment of diseases. However, a major challenge is the identification of therapeutically potent microbial consortia that colonize the host effectively while maximizing immunologic outcome. Here, we propose a novel workflow to select optimal immune-inducing consortia from microbiome compositicon and immune effectors measurements. Using published and newly generated microbial and regulatory T-cell (Treg) data from germ-free mice, we estimate the contributions of twelve Clostridia strains with known immune-modulating effect to Treg induction. Combining this with a longitudinal data-constrained ecological model, we predict the ability of every attainable and ecologically stable subconsortium in promoting Treg activation and rank them by the Treg Induction Score (TrIS). Experimental validation of selected consortia indicates a strong and statistically significant correlation between predicted TrIS and measured Treg. We argue that computational indexes, such as the TrIS, are valuable tools for the systematic selection of immune-modulating bacteriotherapeutics.

Funder

National Institutes of Health

Defense Advanced Research Projects Agency

Human Frontier Science Program

Takeda Science Foundation

National Institute of General Medical Sciences

Japan Agency for Medical Research and Development

National Institute of Allergy and Infectious Diseases

National Science Foundation

Core Research for Evolutional Science and Technology

Brigham and Women's Hospital

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3